TY - JOUR
T1 - Mechanical Low-Pass Filtering of Cells for Detection of Circulating Tumor Cells in Whole Blood
AU - Suzuki, Taiki
AU - Kaji, Noritada
AU - Yasaki, Hirotoshi
AU - Yasui, Takao
AU - Baba, Yoshinobu
N1 - Funding Information:
This work was partially supported by JST/PRESTO [grant number JPMJPR16F4, JPMJPR151B], Grant-in-Aid for Scientific Research on Innovative Areas [18H04545], Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), a JSPS Grant-in-Aid for Scientific Research (A) [16H0209], the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan), and a research grant from the Nitto Foundation.
Publisher Copyright:
Copyright © 2020 American Chemical Society.
PY - 2020/2/4
Y1 - 2020/2/4
N2 - The detection of circulating tumor cells (CTCs) from liquid biopsies using microfluidic devices is attracting a considerable amount of attention as a new, less-invasive cancer diagnostic and prognostic method. One of the drawbacks of the existing antibody-based detection systems is the false negatives for epithelial cell adhesion molecule detection of CTCs. Here we report a mechanical low-pass filtering technique based on a microfluidic constriction and electrical current sensing system for the novel CTC detection in whole blood without any specific antigen-antibody interaction or biochemical modification of the cell surface. The mechanical response of model cells of CTCs, such as HeLa, A549, and MDA-MB-231 cells, clearly demonstrated different behaviors from that of Jurkat cells, a human T-lymphocyte cell line, when they passed through the 6-μm wide constriction channel. A 6-μm wide constriction channel was determined as the optimum size to identify CTCs in whole blood with an accuracy greater than 95% in tens of milliseconds. The mechanical filtering of cells at a single cell level was achieved from whole blood without any pretreatment (e.g., dilution of lysing) and prelabeling (e.g., fluorophores or antibodies).
AB - The detection of circulating tumor cells (CTCs) from liquid biopsies using microfluidic devices is attracting a considerable amount of attention as a new, less-invasive cancer diagnostic and prognostic method. One of the drawbacks of the existing antibody-based detection systems is the false negatives for epithelial cell adhesion molecule detection of CTCs. Here we report a mechanical low-pass filtering technique based on a microfluidic constriction and electrical current sensing system for the novel CTC detection in whole blood without any specific antigen-antibody interaction or biochemical modification of the cell surface. The mechanical response of model cells of CTCs, such as HeLa, A549, and MDA-MB-231 cells, clearly demonstrated different behaviors from that of Jurkat cells, a human T-lymphocyte cell line, when they passed through the 6-μm wide constriction channel. A 6-μm wide constriction channel was determined as the optimum size to identify CTCs in whole blood with an accuracy greater than 95% in tens of milliseconds. The mechanical filtering of cells at a single cell level was achieved from whole blood without any pretreatment (e.g., dilution of lysing) and prelabeling (e.g., fluorophores or antibodies).
UR - http://www.scopus.com/inward/record.url?scp=85079021078&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079021078&partnerID=8YFLogxK
U2 - 10.1021/acs.analchem.9b03939
DO - 10.1021/acs.analchem.9b03939
M3 - Article
C2 - 31922717
AN - SCOPUS:85079021078
SN - 0003-2700
VL - 92
SP - 2483
EP - 2491
JO - Analytical Chemistry
JF - Analytical Chemistry
IS - 3
ER -